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ABSTRACT
Introduction: Approximately 30% of patients who suffer cirrhosis maybe diabetic, called hepatogenous 
diabetes (HD). Insulin resistance seems to be the pathophysiologic basis for HD. Aims of this study were to 
evaluate the glucose metabolism disorders in liver cirrhosis patients and to observe the insulin resistance in HD.
Method: This study was conducted from February-July 2013 in Koja Hospital Jakarta. In the first phase, 
with observational design, inclusion criteria were liver cirrhosis and exclusion was an acute complication. 
We recorded their oral glucose tolerance test (OGTT). Patients who met the HD criteria were continued to 
the second phase, using analytic design, and were compared with type 2 diabetes mellitus (T2DM) patients as 
control. Mean differences of 2-hours postprandial plasma glucose/fasting plasma glucose (2hPPG/FPG) ratio, 
as well as fasting insulin levels between both groups were assessed.
Results: Twenty four patients were included in our study. Normal glucose tolerance test were noted in 7 
(29%) patients, impaired glucose tolerance (IGT) in 6 (25%) patients and HD in other 11 (46%) patients. In 
the second phase, we obtained the ratio of 2hPPG/FPG in HD was 2 ± 0.5 and T2DM was 1.5 ± 0.4 (p = 0.01). 
Mean fasting insulin levels in HD was 10.8 ± 4.2 µIU/mL, while T2DM was 9.3 ± 5.3 µIU/mL (p = 0.5). The 
ratio of 2hPPG/FPG was higher in HD compared to T2DM, assuming the role of insulin resistance in HD.
Conclusion: There were impaired glucose metabolism in liver cirrhosis patients, as well as hepatogenous 
diabetes. Insulin resistance and hyperinsulinemia appeared to play role in HD.
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ABSTRAK
Latar belakang: Sekitar 30% penderita sirosis hati juga menderita diabetes melitus, yang dikenal sebagai 
diabetes melitus (DM) tipe sirosis. Resistensi insulin diduga berperan dalam patofisiologinya. Tujuan penelitian 
ini adalah untuk mengevaluasi gangguan metabolisme glukosa pada pasien sirosis hati dan melihat adanya 
pengaruh resistensi insulin pada DM tipe sirosis.
Metode: Penelitian yang dilakukan dalam periode Februari - Juli 2013 di Rumah Sakit Koja Jakarta ini 
dibagi dalam 2 tahap. Tahap pertama menggunakan desain observasional, dimana kriteria inklusi adalah semua 
penderita sirosis hati namun dieksklusi bila mengalami komplikasi akut, untuk kemudian diperiksa toleransi 
glukosanya. Pasien yang memenuhi kriteria DM dilanjutkan ke tahap 2 dengan penderita DM tipe 2 (DMT2) 
sebagai kontrol. Selanjutnya dengan desain analitik dinilai perbedaan rerata rasio glukosa darah 2 jam post 
prandial (GD2PP)/glukosa darah puasa (GDP) dan kadar insulin puasa antara DM tipe sirosis dengan DMT2. 
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Hasil: Didapatkan 24 penderita sirosis hati dengan hasil tes toleransi glukosa menunjukkan 7 (29%) penderita 
normal, 6 (25%) toleransi glukosa terganggu (TGT), dan 11 (46%) DM tipe sirosis. Dari studi analitik tahap 2, 
didapatkan rerata rasio GDPP/GDP pada pasien DM tipe sirosis sebesar 2 ± 0,5 dan pasien DMT2 sebesar 1,5 ± 0,4 
(p = 0,01). Rerata kadar insulin puasa pada pasien DM tipe sirosis 10,8 ± 4,2 µIU/mL dan DMT2 9,3 ± 5,3 µIU/mL 
(p = 0,5). Rasio GDPP/GDP lebih tinggi pada DM tipe sirosis dibandingkan DMT2 dan bermakna secara statistik. 
Simpulan: Dalam penelitian ini didapatkan adanya gangguan metabolisme gula, bahkan DM tipe sirosis 
pada penderita sirosis hati. Pengaruh resistensi insulin dan hiperinsulinemia tampaknya berperan pada DM 
tipe sirosis.
Kata kunci: DM tipe sirosis, DM tipe 2, rasio G2PP/GDP, kadar insulin puasa
INTRODUCTION
Around 17% to 30% of patients who suffer 
cirrhosis maybe clinically diabetic. Diabetes which 
develops as a complication of liver cirrhosis is known 
as “hepatogenous diabetes” (HD). Insulin resistance 
in the muscular, hepatic and adipose tissue as well as 
hyperinsulinemia, seem to be the pathophysiologic 
basis for HD. Impaired response of islet β-cells of the 
pancreas and hepatic insulin resistance are also known 
to be contributing factors.1,2 In Indonesia there were 
limited published articles regarding HD. Formerly, 
a study by Boedisantoso found that in patients with 
liver cirrhosis 25% were impaired glucose tolerance 
(IGT) and 32% were diabetic.2 Another follow-up 
study done in 19853,4 found that the prevalence of 
hepatogenous diabetes were increased to 34.7% and 
48.6%, respectively. After decades there were no other 
published article regarding HD reported locally.
American Diabetes Association (ADA) 2005 
classified diabetes into 4 groups which are: (1) Type 
1: diabetes mellitus or insulin dependent diabetes 
mellitus (IDDM); (2) Type 2: diabetes mellitus or 
non-insulin dependent diabetes mellitus (NIDDM); 
(3) Other types of diabetes mellitus; (4) Gestational 
diabetes mellitus.5 Other types of diabetes mellitus 
which intended in the classification of ADA 2005 refers 
to genetic defects in cell function, genetic defects of 
insulin’s work, pancreatic exocrine gland disease, 
endocrinopathies, drugs or chemicals, infections, 
uncommon forms of immune-mediated diabetes and 
other genetic syndromes associated with diabetes. 
However, hepatogenous diabetes are not included in 
the classification. The fact raises some question, how 
is the existence of HD in the classification of diabetes 
mellitus today.
'Hepatogenous diabetes' is clinically different from 
type 2 diabetes mellitus (T2DM). A study by Compean 
found comparison of HD group to T2DM group with 
a higher 2-hours postprandial plasma glucose/fasting 
plasma glucose (2hPPG/FPG) ratio 2.27 vs. 8.38, fasting 
insulin 23.2 μIU/mL vs. 11.6 μIU/mL and homeostatis 
model assessment insulin resistence (HOMA IR) index 
8.38 vs. 3.52 respectively. This finding reflects the role 
of insulin resistance in the pathogenesis of HD.6 Aims 
of this study were to evaluate the glucose metabolism 
disorders in liver cirrhosis patients and to observe the 
insulin resistance in HD.
METHOD
The study was conducted in Koja Hospital, Jakarta, 
a tertiary goverment hospital from February 2013 - 
July 2013. Inclusion criteria for liver cirrhosis (LC) 
group were all liver cirrhosis patients admitted or 
visited the internal medicine outpatient (IM OPD) 
clinic. Patients were excluded if they experienced an 
acute complication, or if patients documented to have 
hepatoma. This study were divided into two phases; 
initially all patients with liver cirrhosis were collected 
for baseline characteristics: age, sex, glucose tolerance 
tests (GTT) and fasting insulin level. Patients were 
labeled as HD if the 2 hours post prandial plasma 
glucose was ≥ 200 mg/dL. 
From all patients who met the HD criteria, we 
took 9 patients to continue into the second phase. 
The sample size was determined using the formula 
“mean difference between two independent groups”. 
Those 9 patients then were matched with 9 patients 
with T2DM patients as control. Inclusion criteria for 
T2DM group were untreated diabetes, or more than 
two weeks discontinued hypoglycemic agent; sex 
and age were matched with LC group. Data collected 
from both group were fasting insulin, fasting plasma 
glucose, post-prandial plasma glucose, and the ratio 
of 2hPPG/FPG.
Univariate analysis of all qualitative variables were 
presented in n (%) and quantitative variables were 
presented in mean (SD). Independent T-test was used 
to determine mean differences of 2hPPG/FPG ratio and 
fasting insulin levels between HD group and T2DM group. 
All data analysis was done using SPSS version 20.
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RESULT
From February 2013-July 2013, 24 liver cirrhosis 
patients were included in this study. Baseline 
characteristics were described in Table 1.
Table 1. Baseline characteristis of liver cirrhosis patients
Characteristic n (%), mean ± SD
Sex
Male 15 (62.5)
Female 9 (37.5)
Age (years)
< 40 5 (20.8)
40-60 11 (45.8)
> 60 8 (33.4)
Fasting insulin 7.2 ± 5.7
Fasting plasma glucose 107.8 ± 42.4
Post-prandial plasma glucose 205.5 ± 86.4
2hPPG/FPG 1.9 ± 0.4
2hPPG/FPG: ratio of 2 hours postprandial plasma glucose/fasting plasma 
glucose
 From 24 patients, we found that 17 (71%) patients 
with liver cirrhosis have impaired glucose metabolism, 
and 7 (29%) patients have normal glucose tolerance. 
From patients with liver cirrhosis, 6 (25%) patients 
met the criteria for IGT and 11 (46%) people were HD. 
Figure 1 showed the proportion of HD to all patients 
with liver cirrhosis.
Figure 1. Distribution of patients with liver cirrhosis according 
to the oral glucose tolerance test (n = 24)
Table 2. Characteristis of liver cirrhosis group vs. T2DM group
Characteristic
Group of patients
LC T2DM
Sex
Male 6 (66.7) 6 (66.7)
Female 3 (33.3) 3 (33.3)
Age (years)
< 40 1 (11.1) 0 (0)
40-60 5 (55.6) 6 (66.7)
> 60 3 (33.3) 3 (33.3)
Fasting insulin 10.8 ± 4.2 9.3 ± 5.3
Fasting plasma 
glucose
133.7 ± 51.5 210.7 ± 77.6
Post-prandial plasma 
glucose
263.8 ± 73.3 304.6 ± 59.9
2hPPG/FPG 2 ± 0.5 1.5 ± 0.4
2hPPG/FPG: ratio of 2 hours postprandial plasma glucose/fasting plasma 
glucose; LC: liver cirrhosis; T2DM: type 2 diabetes mellitus
 
Figure 2. Mean 2-hours post-prandial glucose/fasting plasma 
glucose (2hPPG/FPG) in hepatogenous diabetes (HD) and type 
2 diabetes mellitus groups (T2DM) (p = 0.01)
Figure 3. Mean fasting insulin level in hepatogenous diabetes 
(HD) and type 2 diabetes mellitus (T2DM) groups (p = 0.5)
The 2-hours postprandial plasma glucose/fasting 
plasma ratio in HD group was 2 ± 0.5 and T2DM was 
1.5 ± 0.4 (p = 0.01). Meanwhile, mean fasting insulin 
levels in patients with HD was 10.8 ± 4.2 µIU/mL and 
T2DM was 9.3 ± 5.3 µIU/mL (p = 0.5).
From 11 patients with HD, 9 patients rendered to 
the second phase. Nine T2DM patients were taken as 
controls. Characteristics of LC group and T2DM group 
were described in Table 2.
This study included 9 patients who met criteria for 
HD and compared them with control group. In both 
groups, we collect the fasting plasma glucose (FPG), 
2-hours postprandial plasma glucose (2hPPG), and 
fasting insulin. The insulin resistances were assessed 
by measuring the ratio of 2hPPG/FPG (Figure 2) and 
fasting insulin levels (Figure 3).
HD = 11 (46%)
patients
normal = 7 (29%)
patients
IGT = 6 (25%)
patients
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DISCUSSION
Hepatogenous diabetes is generally subclinical, 
and commonly has a normal fasting glucose level; 
that is why the oral glucose tolerance test (OGTT) 
is obligatory to establish the diagnosis.6 From the 
OGTT results, 11 (46%) patients were diabetic, 6 
(25%) patients have impaired glucose tolerance 
and only 7 (29%) patients have normal glucose 
metabolism. A study by Compean, in patients with 
liver cirrhosis noted 96% of patients have impaired 
glucose metabolism and 30% of them were HD.6 
In our data, we documented 71% of patients have 
impaired glucose metabolism and 65% of them were 
HD. Compared to the previous study, less patients have 
impaired glucose metabolism (71% vs. 96%), but more 
patients met the criteria for hepatogenous diabetes 
(46% of the total patients, 65% of total impaired 
glucose metabolism). Liver plays an important role in 
the metabolism of carbohydrates, particularly through 
the process of glycogenogenesis and glycogenolysis.7,8 
In the presence of chronic liver disease, glucose 
metabolism is weaken, meanwhile insulin resistance, 
glucose intolerance and hepatogenous diabetes 
developed. Insulin resistance and hyperinsulinemia 
are postulated as a pathophysiology basis for cirrhosis 
type diabetes mellitus.9 Management of HD is slightly 
different from type 2 DM because in HD, we rarely 
record microangiopathy and physician must be more 
vigilant to anticipate the hepatotoxic effects of oral 
hypoglycemic agents. However, in the classification 
of diabetes according to the ADA 2005 the term 
"hepatogenous diabetes" was not explicitly stated as 
one of other types of DM.5,6
To determine hyperinsulinemia, fasting insulin 
levels was examined in all 24 patients. We obtained 17 
(70.8%) patients had normal fasting insulin  (2.6-24.9 
μIU/mL), 4 (16.7%) had low fasting insulin (< 2.6 μIU/
mL) and 3 (12.5%) had high fasting insulin (> 24.9 
μIU/mL). Kawaguchi recorded approximately 57% of 
patients with liver cirrhosis showed an increase insulin 
resistance.10 Insulin level in patients with HD was 
higher than T2DM. Hyperinsulinemia in liver cirrhosis 
could be due to damage to the liver parenchymal cells, 
causing impaired insulin degradation. In this study, 
12.5% patients were hyperinsulinemia.
Mean fasting insulin levels in HD group were 
compared to the T2DM group. Insulin levels in HD 
patients were 10.8 ± 4.2 µIU/mL and in T2DM patients 
were 9.3 ± 5.3 µIU/mL (p = 0.5). These data indicated 
a relative hyperinsulinemia in HD group compared to 
the T2DM (10.8 ± 4.2 µIU/mL vs. 9.3 ± 5.3 µIU/mL), 
but apparently this difference was not statistically 
significant. This was likely due to the small sample 
size, less accurate technique of blood sampling, or 
laboratory error.
Furthermore, the 2hPPG/FPG ratio was assessed in 
both groups. The higher ratio 2hPPG/FPG indicated 
the failure of insulin to enter glucose into the cells, 
therefore the higher the ratio, the higher the insulin 
resistance. In HD group, we found that 2hPPG/FPG 
ratio was 2 ± 0.5 and 1.5 ± 0.4 in T2DM (p = 0.01). 
The 2hPPG/FPG ratio was higher in HD group, and 
was statistically significant. These data supported the 
existence of a higher insulin resistance in HD compared 
with T2DM.
CONCLUSION
There were impaired glucose metabolism in liver 
cirrhosis patients, as well as hepatogenous diabetes. 
Insulin resistance and hyperinsulinemia appear to play 
a role in HD. Correspondent with the high prevalence 
of hepatogenous diabetes in this study as well as 
others, we propose to include hepatogenous diabetes 
in the classification of diabetes mellitus as a subtype 
of other specific types.
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